Android
Zerodha Broker (Free Delivery)

India's No. 1 Broker with Best Software Trade @ Flat Rs 20

Open Instant Account
market update arrow Apple iPhones may need redesign as European Union pushes for common charger arrow Freshworks m-cap crosses $13 bn; over 10% employees turn 'crorepatis' arrow PM Modi meets leading American CEOs; encourages them to invest in India arrow PM Modi discusses India's RE landscape with US-based solar manufacturer arrow Dow jumps nearly 500 pts as economically sensitive sectors bounce arrow YES Bank gets tough on DISH TV promoters, calls EGM to replace firm's board arrow Did Subhash Chandra beat a US activist fund with Zee-Sony merger? arrow Merger of Sony, Zee to create TV powerhouse challenging Disney arrow Govt allows Covid vaccines at home to those with restricted mobility arrow Covid LIVE: Kerala sees 19,682 new cases, 152 deaths in last 24 hrs arrow Amazon creates 110,000 seasonal jobs in India ahead of festive season arrow HC reserves orders on bail pleas of wife, daughters of Yes Bank founder arrow Accenture expects strong Q1 as Delta variant delays return-to-work plans arrow China preparing for potential downfall of Evergrande: Report arrow Sensex ends at record high, eyes 60,000: 3 factors behind the rally arrow Sensex ends 958 pts up at 59,885, Nifty tops 17,800; Realty index gains 9% arrow Jio, Airtel add mobile subscribers in July, VIL loses 1.4 mn users: Trai arrow Tata Motors DVR hits over 3-yr high; gains 12% on the back of heavy volumes arrow Infosys, I-T Dept working to fix e-filing glitches, 30 mn transactions done arrow Pegasus controversy: SC to set up probe panel, give formal order next week arrow JBF Ind hits 5% upper circuit for 2nd straight day on RIL takeover buzz arrow RBL Bank MD Vishwavir Ahuja gets shareholders' nod at AGM for fourth term arrow Google files writ in Delhi HC against CCI alleging confidential report leak arrow DATA STORY: India reports 31,923 new cases, 282 deaths added to toll arrow Housing financiers on a roll; Can Fin hits record high, Repco Home gains 8%

SUN PHARMACEUTICAL INDUSTRIES LTD.769.85 -0.25 (-0.03%)

  • BSE: 533316
  • |
  • NSE: SUNPHARMA
  • |
  • ISIN NO: INE044A01036
  • |
  • INDUSTRY: Pharmaceuticals
Price table
Date Open High Low Close Volume Delivery % 20-Day SMA 50-Day SMA 200-Day SMA
23-Sep-2021 771.10 777.20 766.10 769.85 2109768 45.71 777.20 756.85 660.80
22-Sep-2021 765.00 774.00 764.50 770.10 1817865 49.55 777.15 754.80 659.70
21-Sep-2021 756.50 766.35 751.05 764.50 2123997 46.93 777.20 752.75 658.55
20-Sep-2021 766.70 774.75 751.60 756.50 2206369 49.66 776.95 750.80 657.30
17-Sep-2021 785.00 787.90 766.65 769.90 4052622 64.31 777.20 749.30 656.05
16-Sep-2021 780.00 784.55 778.30 781.05 1353677 51.13 777.85 747.35 654.75
15-Sep-2021 784.70 785.75 778.80 780.65 1393824 46.06 778.00 745.35 653.45
Key Data
  • Market cap 163059.00 CR.
  • Book value 188.00
  • Stock P/E 40
  • Dividend Yield 0.81%
  • ROCE 10.50%
  • ROE 9.06%
  • Sales Growth (3Y) 0.00%
  • Face Value (3Y) 1.00
SUNPHARMA Share Price:

SUNPHARMA share is currently trading at 769.85 at the PE of 40.

The 52-week range of SUNPHARMA share price is 452.25 ~ 804.35

SUNPHARMA share has a current face value of ₹1.00/-

Profile

SUNPHARMA

SUNPHARMA

Sun Pharmaceutical Industries began with just five products for treating psychiatry ailments in the year 1983. Its sales were initially limited to only two states such as West Bengal and Bihar. Soon, its sales were rolled out nationally in the year 1985. Also, the products being used in cardiology were introduced in 1987, and Monotrate, which is one of the first products introduced at that time, it became one of our largest selling products. Also, several ... other vital products in Cardiology were added; and several of these were being introduced in India. It was also listed on the main stock exchanges in India in 1994. It is an international specialty pharma company, along with a presence in 30+ markets. It also makes several active pharmaceutical ingredients. And in branded markets, its products are recommended in chronic therapy areas such as psychiatry, cardiology, neurology, diabetology, gastroenterology, and respiratory. Also, knowing the fact that research is a critical growth driver, they soon established their research center SPARC in 1993, and it created a base of robust product and process development skills. In India, it has reached leadership in almost each of the therapy areas where we operate, and it’s also rated among the leading companies by key customers. So, growing market share and retaining this customer focus persists to be a high priority area for the company. The other API plant, its Ahmednagar plant, was being acquired from the multinational Knoll Pharmaceuticals in 1996, and also upgraded for approvals from regulated markets, along with substantial capacity besides over the years. It was the first of many sensibly priced acquisitions, each of that would bring essential parts to the long-term strategy. Also, with world-class technology and a team of robust professionals, it built sites and systems that could meet the most stringent international manufacturing standards. Also, the expert quality teams ensure that both systems and processes remain in compliance, along with the latest standards. Also, several plants hold approvals from both the USFDA and the UK MHRA. Both APIs and Dosage forms were made in 19 sites across India, Hungary, the US, and Bangladesh.

  • Formulation:It is a market leader in specialty therapy areas, along with high-quality brands trusted for the chronic disease. Its comprehensive product basket and products, along with technology-based differentiation, are the highlights. It makes specialty formulations across a spectrum of dosage forms such as oral, injectable, and delivery system based.
  • API:Its API (or Active Pharmaceutical Ingredients) program started in 1995 with a simple objective- of facilitating the manufacture of complicated formulations, and for that sourcing the API will restrict entry. It also makes specialty APIs that include steroids, peptides, hormones, and anticancer at an internationally approved world-class site. It also has over 1600 registrations in 30 countries, and more than 1000 registrations filed and pending approval. In such countries, it uses the same approach to specialty brand building as well as customer focus that has worked for it in India.

The Manufacturing of product in the following therapy areas:

  • CNS disorders
  • Cardiology
  • Diabetes and Metabolic disorders
  • Gastroenterology
  • Ophthalmology
  • Oncology
  • Pain
  • Allergy, Asthma, and Inflammation
  • Gynecological

Some Other group companies:

  • Caraco Pharmaceutical Laboratories:It is based in Detroit, Michigan. Caraco develops, and manufactures, and markets and distributes generic and private-label pharmaceuticals and markets them across the United States.
  • Sun Pharmaceutical Industries Inc. (or SPI):It is a Michigan Corporation and a wholly-owned subsidiary of Sun Pharmaceutical Industries Ltd, India. Its plant is spread over 35,000 sq ft, in Bryan, Ohio, and manufactures creams, liquids, and ointments. It was being purchased from Valeant Pharma.
  • Sun Pharmaceutical (Bangladesh):It is a private limited company and was incorporated in March 2001 under the Companies Act 1994. It was formed joined with Sun Pharma, City Overseas Ltd, which is a company incorporated in Bangladesh and Sun Pharma Global Inc, which is a company that was incorporated under the laws of the British Virgin Islands. It began its commercial operations on October 2004. It owns and operates a pharmaceutical factory and also makes pharmaceutical products that are being sold in the local market.
  • Alkaloids Chemical Company Exclusive Group Ltd.:ICN Hungary, acquired from Valeant Pharmaceuticals in 2005, it is one of the few units globally and authorized to make controlled substances. Also, ICN Hungary is renamed as Alkaloids Chemical Company.

Some of the Milestones:

  • 2008:In November 2008, it along with its subsidiaries, acquired 100% ownership of the Chattem Chemicals, Inc., which is a narcotic raw material importer and manufacturer of the controlled substances with an approved facility in Tennessee. It will offer vertical integration for all of its controlled substance dosage form businesses in the US.
  • 2011:Dilip Shanghvi, CMD, also received the E&Y Entrepreneur of the Year Award in 2010. (ORG – Operations Research Group Audit of the Retail Chemist Sales, soon after renamed the IMS - ORG Retail Store Audit. Also, both ORG and IMS are the trademarks of their registered owners).
  • 2014:On April 6, 2014, the Sun Pharmaceutical Industries and Ranbaxy Laboratories declared that they have entered into definitive agreements according to which Sun Pharma would acquire 100% of Ranbaxy in an all-stock transaction.

Some of the Achievements:

  • It was also selected as the best company by Express Pharma Pulse, for overall performance in 2002.
  • The four manufacturing sites won the prestigious IDMA awards.
  • The Forbes Global ranked Sun Pharma in the list of the best small 200 companies for 2003.
  • The Forbes Global ranked Sun Pharma in the list of most valuable companies for 2004.

Read More
Trend Analysis
  • Short Term Trend :
    Up
  • Medium Term Trend :
    Not Clear
  • Long Term Trend :
    Not Clear

Are you friends with trend?

There is a saying in stock market, "Trend is your best friend"

It means, a good trader doesn't place his money against the trend. Many new traders lose money because they are trying to catch trend reversals but seasoned traders wait for a clear trend to emerge before taking the trade in the direction of trend.

Day Technicals

What is Opening Range Breakout?

An opening range breakout is breaking out of the day's range after a stock has moved for some time in a sideways trend. In technical terms, its a breakout from the support and resistance level in an upward or downward trend.

NR7

What is NR7 trading strategy?

Narrow Range trading strategy or NR7 Trading strategy is a breakout based method which assumes that the price of security trends up or down after a brief consolidation in a narrow range.

Opening Price clues

How to use Opening Price Clues in your trades?

If the stock has same open and high after it has traded for some time, it implies there was a consistent selling pressure that didn't allow the stock to move higher from the opening price. Similarly, if the stock has same open and low price, it implies there was a consistent buying intent that kept the stock price above the opening price.

Day High Low Range
TIME LOWEST HIGHEST
10 AM - -
11 AM - -
12 PM - -
1 PM - -
2 PM - -
Japanese Candlestick Patterns
Candle Pattern 1 :None
Candle Pattern 2 : None
Candle Pattern 3 :None
Candlestick Price Action
Higher High Higher Low
Pivot Points
Name S4 S3 S2 S1 Pivot Points R1 R2 R3 R4
classic 741.03 750.53 760.03 765.07 769.53 774.57 779.03 788.53 798.03
woodie's 741.24 750.74 757.62 760.25 767.12 769.75 776.62 779.25 788.75
fibonacci - 760.03 763.66 765.90 769.53 773.16 775.41 779.03 -
camarilla 764.88 767.49 768.36 769.23 -- 770.97 771.84 772.71 775.32
Past Performance & Moving Averages
Day’s LOW HIGH RANGE SMA Stock PERFORMANCE Nifty PERFORMANCE
10 DAY
751.05
788.00
773.06 -0.20 % 1.61 %
20 DAY
751.05
803.90
777.18 -1.77 % 1.94 %
50 DAY
669.00
804.35
756.84 -1.23 % 8.47 %
100 DAY
642.00
804.35
717.83 14.64 % 10.76 %
200 DAY
539.70
804.35
660.82 25.98 % 17.61 %
YTD
550.40
804.35
670.46 31.45 % 25.41 %
52 Week
452.25
804.35
628.89 33.13 % 23.37 %

Why are moving Averages important in technical Analysis?

An opening range breakout is breaking out of the day's range after a stock has moved for some time in a sideways trend. In technical terms, its a breakout from the support and resistance level in an upward or downward trend.

Gaps On Day Chart
Industry Growth Rate

In Last 1 Year the industry has grown by 9.06 %

In Last 5 Year the industry has grown by 6.15 %

Peer comparison

Sales

COMPANY NAME 2015 2016 2017 2018 2019 2020
SUNPHARMA 27392.00 28487.00 31578.00 26489.00 29066.00 32838.00
LUPIN 12770.00 14256.00 17367.00 15797.00 16718.00 15375.00
DRREDDY 15023.00 15568.00 14196.00 14281.00 15448.00 17517.00
CIPLA 11345.00 13790.00 14394.00 15156.00 16362.00 17132.00
AUROPHARMA 12103.00 13772.00 14910.00 16463.00 19564.00 23099.00
Total 78633.00 85873.00 92445.00 88186.00 97158.00 105961.00

Financial

LAST FISCAL CURRENT GROWTH 10 YEAR CAGR
S.NO. COMPANY NAME MARKET CAP CMP BOOK VALUE EPS STOCK P/E ROE ICR REVENUE NET PROFIT NPM REVENUE NET PROFIT REVENUE NET PROFIT
1 SUN PHARMACEUTICAL INDUSTRIES LTD. 184903.08 770.55 98.33 15.69 27.17 15.69 22.95% 32838.00 3765.00 11.47% 12.98% 41.28% 23.41% 10.79%
2 MARKSANS PHARMA LTD. 285679.64 69.60 11.85 2.86 7.08 2.85 21.33% 1134.00 117.00 10.32% 13.40% 53.95% 12.19% 0.00%
3 MOREPEN LABORATORIES LTD. 260419.13 57.85 6.43 0.75 19.67 0.38 34.50% 853.00 34.00 3.99% 10.92% 17.24% 15.16% 0.00%
4 NEULAND LABORATORIES LTD. 201182.39 1570.00 542.16 12.63 37.00 1.23 4.64% 763.00 16.00 2.10% 14.39% 0.00% 10.62% 0.00%
5 Gufic BioSciences Ltd. 156780.91 201.75 10.85 2.94 24.32 2.88 3.46% 358.00 23.00 6.42% 1.99% 4.55% 19.36% 36.83%
6 DIVI'S LABORATORIES LTD. 138331.72 5213.10 266.77 51.85 37.86 25.98 260.43% 5394.00 1377.00 25.53% 9.06% 1.77% 19.07% 15.01%
7 DR.REDDY'S LABORATORIES LTD. 79679.73 4796.00 852.69 121.92 25.70 24.41 25.28% 17517.00 2026.00 11.57% 13.39% 3.90% 9.56% 19.13%
8 RPG LIFE SCIENCES LTD. 41788.21 252.45 105.02 17.54 16.28 2.23 20.00% 376.00 29.00 7.71% 13.94% 163.64% 8.99% 10.18%
9 Gland Pharma Ltd 63906.79 3908.85 242.00 0.00 0.00 48.31 136.43% 2633.00 773.00 29.36% 28.82% 71.02% 0.00% 0.00%
10 SMS PHARMACEUTICALS LTD. 34236.68 40.25 42.07 3.73 11.38 4.00 6.67% 412.00 32.00 7.77% -11.40% -20.00% 0.00% 0.00%
11 CIPLA LTD. 78021.52 968.05 209.71 19.18 23.33 9.61 16.27% 17132.00 1547.00 9.03% 4.71% 1.24% 12.32% 3.63%
12 TORRENT PHARMACEUTICALS LTD. 52607.54 3107.35 323.66 60.55 33.05 12.06 4.81% 7939.00 1025.00 12.91% 3.47% 135.09% 15.46% 16.07%
13 PIRAMAL ENTERPRISES LTD. 62679.70 2778.95 823.58 1.07 1363.55 0.53 1.18% 13068.00 24.00 0.18% -1.11% -98.37% 13.68% -25.92%
14 LUPIN LTD. 42611.51 940.40 384.76 -5.95 0.00 -2.96 6.19% 15375.00 -269.00 -1.75% -8.03% -144.32% 12.41% NaN
15 NECTAR LIFESCIENCES LTD. 65333.75 29.15 49.89 1.42 9.79 1.45 1.75% 2363.00 32.00 1.35% -14.97% -33.33% 10.86% -10.02%
16 AUROBINDO PHARMA LTD. 42963.26 733.60 206.07 48.32 10.51 47.98 15.90% 23099.00 2831.00 12.26% 18.07% 19.70% 20.72% 17.53%
17 Alkem Laboratories Ltd 47590.33 3964.20 501.34 94.26 25.32 46.96 22.66% 8344.00 1127.00 13.51% 13.42% 48.09% 0.00% 0.00%
18 ABBOTT INDIA LTD. 45981.36 21565.05 1004.00 279.04 46.86 28.24 84.11% 4093.00 593.00 14.49% 11.25% 31.78% 0.00% 0.00%
19 CADILA HEALTHCARE LTD. 58058.99 566.90 90.85 11.49 23.64 11.54 8.04% 14253.00 1177.00 8.26% 8.26% -36.34% 14.84% 8.83%
20 GLAXOSMITHKLINE PHARMACEUTICALS LTD. 25544.96 1508.25 138.61 5.50 250.36 0.55 18.00% 3224.00 93.00 2.88% 3.07% -79.10% 0.00% 0.00%
Sales

What is Sales Trend ?

Sales trend is a methodology to understand sales results which helps in understanding the trends of the market over a specific period of time. Sales results are an indicative of the sales patterns followed by the customer over a time period.

Profitability
Net Profit
EPS

What is EBITDA Margin & EBIT Margin ?

Corporate accounting is required to adhere to the standards and practices collectively referred to as the generally accepted accounting principles. EBITDA is an excellent way for corporate accountants to start compiling data, but it should not be considered an absolute result. This is due to the fact that many consider EBITDA more of a broad stroke than a definitive form of accounting practice.

EBITDA Margin
EBIT Margin
NPM
Cash Flow

Why is the Cash Flow Analysis important?

A business needs cash to pay its expenses, to pay bank loans, to pay taxes and to purchase new assets. A cash flow report determines whether a business has enough cash to do exactly this.

Operating Activities
Financing Activities
Investing Activities
Financial Health

What Is Financial Health?

Financial health is a term used to describe the state of one's personal monetary affairs. There are many dimensions to financial health, including the amount of savings you have, how much you’re putting away for retirement, and how much of your income you are spending on fixed or non-discretionary expenses.

Debt to Equity
Piotroski Score
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9

What Is the Piotroski Score?

The Piotroski score is a discrete score between 0-9 that reflects nine criteria used to determine the strength of a firm's financial position.

Altman Z Score (Mfg Company)
  • Distress (< 1.81)
  • Caution (>1.81 < 2.99)
  • 5.48
    Safe (3 & above)
Altman Z Score (Non-Mfg Company)
  • Distress ( < 1.23)
  • Caution (>1.23 < 2.6)
  • 10.17
    Safe (2.6 & above)
Valuation

What Is Valuation?

Valuation is the analytical process of determining the current (or projected) worth of an asset or a company. There are many techniques used for doing a valuation. An analyst placing a value on a company looks at the business's management, the composition of its capital structure, the prospect of future earnings, and the market value of its assets, among other metrics.

SUNPHARMA: Future
TRADING SYMBOL OI VOLUME LAST PRICE LOT SIZE EXPIRY DATE
SUNPHARMA21SEPFUT 21595000.00 32795000.00 85.05 1400.0 2021-09-30
SUNPHARMA21OCTFUT 0.0 0.0 0.0 1400.0 2021-10-28
SUNPHARMA21NOVFUT 0.0 0.0 0.0 1400.0 2021-11-25
ROLLOVER COST: -100.00% (INR -85.05)
ROLLOVER%:0.00%
What is the significance of Rollover data?

Rollover in an important data point and should be analyzed in the expiry week. Rollover involves carry forwarding of ‘futures’ positions from one series (which is nearing expiry date) to the next one.

Rollover percentage actually indicates whether the traders are willing to carry forward their existing. positions (long or short) to the next series or not. Generally, the rollover figures alone will not indicate which direction traders are betting on. You should also check whether absolute open interest is increasing or decreasing over expiries

What is Options Max Pain Theory?

Options Max Pain Theory suggests,

“On option expiration day, the underlying stock price often moves toward a point that brings maximum loss to option buyers.”

Bulk Deals
Symbol Name Deal Date Client Name Transcation Type Quantity Price
SUNPHARMA 2016-04-11 GENESIS INDIAN INVESTMENT COMPANY LIMITED S 15858723.00 816.69
SUNPHARMA 2016-04-11 GENESIS EMERGING MARKETS L P P 15858723.00 816.69
SUNPHARMA 2016-03-14 GENESIS INDIAN INVESTMENT COMPANY LIMITED S 15850000.00 864.01
SUNPHARMA 2016-03-14 GENESIS EMERGING MARKETS L P P 15850000.00 864.01
SUNPHARMA 2007-06-22 DEUTSCHE SECURITIES MAURITIUS LIMITED P 997500.00 1061.65
SUNPHARMA 2005-06-16 RAKSHA S VALIA S 110000.00 562.45
SUNPHARMA 2005-06-16 LAKSHADEEP INVESTMENT AND P 110000.00 562.45
SUNPHARMA 2005-02-24 CAPITAL INTERNATIONAL INC S 2020000.00 475.11
Block Deals
Symbol Name Deal Date Client Name Transcation Type Quantity Price
SUNPHARMA 2021-04-22 ISHARES EM ASIA MAURITIUS CO S 157552.00 645.15
SUNPHARMA 2021-04-22 ISHARES MSCI EMERGING MARKETS ASIA ETF P 157552.00 645.15
SUNPHARMA 2021-04-08 THE MTBJ LTD. AS TRST FOR GOVERNMENT PENSION INVESTMENT FUND MTBJ400045849 P 393281.00 620.80
SUNPHARMA 2021-04-08 THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MUTB400045794 S 393281.00 620.80
SUNPHARMA 2021-03-04 VFTR C INSTITUTIONAL TOTAL INTERNATIONAL STOCK MARKET INDEX TRUST II P 356363.00 620.30
SUNPHARMA 2021-03-04 VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND S 356363.00 620.30
SUNPHARMA 2021-02-25 VFTR C INSTITUTIONAL TOTAL INTERNATIONAL STOCK MARKET INDEX TRUST II P 381272.00 602.70
SUNPHARMA 2021-02-25 VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND S 381272.00 602.70
SUNPHARMA 2021-02-04 VFTR C INSTITUTIONAL TOTAL INTERNATIONAL STOCK MARKET INDEX TRUST II P 411575.00 629.65
SUNPHARMA 2021-02-04 VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND S 411575.00 629.65
SUNPHARMA 2021-01-28 VFTR C INSTITUTIONAL TOTAL INTERNATIONAL STOCK MARKET INDEX TRUST II P 365400.00 566.80
SUNPHARMA 2021-01-28 VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND S 365400.00 566.80
SUNPHARMA 2021-01-14 VFTR C INSTITUTIONAL TOTAL INTERNATIONAL STOCK MARKET INDEX TRUST II P 369688.00 602.40
SUNPHARMA 2021-01-14 VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND S 369688.00 602.40
SUNPHARMA 2020-12-03 VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND S 398808.00 545.45
SUNPHARMA 2020-12-03 VFTR C INSTITUTIONAL TOTAL INTERNATIONAL STOCK MARKET INDEX TRUST II P 398808.00 545.45
SUNPHARMA 2020-11-13 VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND S 423274.00 507.75
SUNPHARMA 2020-11-13 VFTR C INSTITUTIONAL TOTAL INTERNATIONAL STOCK MARKET INDEX TRUST II P 423274.00 507.75
SUNPHARMA 2020-10-28 VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND S 431220.00 469.70
SUNPHARMA 2020-10-28 VFTR C INSTITUTIONAL TOTAL INTERNATIONAL STOCK MARKET INDEX TRUST II P 431220.00 469.70
SUNPHARMA 2020-10-15 VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND S 432495.00 500.80
SUNPHARMA 2020-10-15 VFTR C INSTITUTIONAL TOTAL INTERNATIONAL STOCK MARKET INDEX TRUST II P 432495.00 500.80
SUNPHARMA 2020-09-30 VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND S 441582.00 505.55
SUNPHARMA 2020-09-30 VFTR C INSTITUTIONAL TOTAL INTERNATIONAL STOCK MARKET INDEX TRUST II P 441582.00 505.55
SUNPHARMA 2019-03-19 GUJARAT STATE FINANCIAL SERVICES LTD P 505265.00 466.25
SUNPHARMA 2019-03-19 GUJARAT STATE INVESTMENTS LIMITED S 505265.00 466.25
SUNPHARMA 2017-10-27 MERRILL LYNCH MARKETS SINGAPORE PTE. LTD. P 129204.00 536.00
SUNPHARMA 2017-10-27 MERRILL LYNCH CAPITAL MARKETS ESPANA SA SV S 129204.00 536.00
SUNPHARMA 2016-02-23 NEW INDIA INVESTMENT COMPANY MAURITIUS LIMITED S 320500.00 886.80
SUNPHARMA 2016-02-23 NEW INDIA INVESTMENT TRUST PLC P 320500.00 886.80
SUNPHARMA 2013-02-01 LIBERTY MUTUAL RETIREMENT PLAN MASTER TRUST P 258513.00 720.00
SUNPHARMA 2013-02-01 MICM-LIBRTY LIFE ASUR CO BOSTON NEWPORT TIGER S 258513.00 720.00
SUNPHARMA 2011-10-17 ISHARES MSCI INDIA MAURITIUS COMPANY P 120311.00 477.50
SUNPHARMA 2011-10-17 HSBC BANK (MAURITIUS) LIMITED S 120311.00 477.50
SUNPHARMA 2010-01-14 CITIGROUP GLOBAL MARKETS MAURITIUS PRIVATE LIMITED S 35385.00 1558.00
SUNPHARMA 2010-01-14 SWISS FINANCE CORPORATION (MAURITIUS) LTD P 35385.00 1558.00
SUNPHARMA 2010-01-13 CREDIT SUISSE (SINGAPORE) LIMITED A/C CREDIT SUISSE (SINGAPO P 35385.00 1563.00
SUNPHARMA 2010-01-13 CITIGROUP GLOBAL MARKETS MAURITIUS PRIVATE LIMITED S 35385.00 1563.00
Dividend history
Bonus Data
Company Name Split Date From Value To Value
SUN PHARMACEUTICAL INDUSTRIES LTD. 2013-07-29 1.00 1.00
Split Data
Company Name Split Date From Value To Value
SUN PHARMACEUTICAL INDUSTRIES LTD. 2010-11-25 5.00 1.00